Drawing on signaling theories from marketing and economic sociology, I argue that the benefits of occupying an advantageous structural position vary with the observability of quality at the field level. Using a unique dataset collected from three distinct sources, Measures of  are derived from textual analysis of the Bioworld archives and are shown to impact the trading volume, idiosyncratic risk and abnormal returns of publicly-traded biotechnology firms. These effects are moderated by a firm's position in a network of strategic alliances.
TBW: Max 350 words